Amoy Diagnostics AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies The Japanese MHLW approved the real-time PCR-based test as a CDx to detect four driver genes for nine associated NSCLC targeted therapies. AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance The companies have worked together on a number of other cancer-related projects, including a companion diagnostic for the ovarian cancer treatment olaparib. Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China AmoyDx will develop and seek regulatory approval in China for a lung cancer PCR panel to be used with Merck's MET inhibitor tepotinib. Amoy Diagnostics, Haihe Pharmaceutical Ink Agreement to Codevelop CDx for Lung Cancer Treatment Amoy will develop its AmoyDx Pan Lung Cancer PCR Panel (9-in-1 Plus) as a companion diagnostic test for Haihe's MET kinase inhibitor Glumetinib. AmoyDx Strikes CDx Development Deal for Merck KGaA Cancer Drug AmoyDx aims to develop a companion diagnostic for Merck KGaA's non-small cell lung cancer treatment Tepmetko, which was recently approved in Japan. Mar 25, 2020 AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic Jan 3, 2020 Massachusetts Startup Focuses on Long-Read Sequencing Technology Premium Nov 25, 2019 AmoyDx, Eisai Form CDx Development Alliance Oct 4, 2019 In Brief This Week: Thermo Fisher, HalioDx, OncoCyte, Amoy Diagnostics, More Jun 24, 2019 AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy Mar 1, 2019 AmoyDx Wins Chinese Regulatory Approval for BRCA Mutation Test Jan 29, 2019 AmoyDx, Sanomics Ink Deal for Multigene Mutation Detection Kit Oct 12, 2018 AmoyDx Lung Cancer CDx Approved in South Korea Jan 29, 2018 AmoyDx, Medikonia Ink MDx Distribution Deal Jan 22, 2018 AmoyDx Wins Chinese Approval for Lung Cancer Liquid Biopsy CDx May 16, 2017 Amoy Dx Partners With Canbridge on CDx Development Feb 3, 2017 Japan Regulators Approve AmoyDx's Lung Cancer CDx Jul 28, 2016 Merck KGaA, AmoyDx Partner on Colorectal Cancer Test for Chinese Market Oct 1, 2015 AmoyDx, Illumina Partner to Develop NGS Cancer Diagnostics for Chinese Clinical Oncology Market Oct 24, 2014 Amoy Diagnostics Obtains CE Mark for Cancer Mutation Assays Oct 17, 2014 MoBiTec to Distribute Amoy's MDx Products in Germany Sep 3, 2014 Chinese Regulators Approve AmoyDx's ALK, ROS1 Gene Fusion Detection Kits Aug 29, 2013 OxOnc to Use Amoy Gene Fusion Kits in Trial of Pfizer Drug Mar 20, 2013 AmoyDx Cancer Detection Kit Approved by Chinese Regulators Jan 25, 2013 In Brief This Week: Syapse; Amoy Diagnostics; Precision Therapeutics, Med BioGene; Abbott Load More Breaking News Lunaphore Technologies, University of Bern Partner on Colorectal Cancer Study People in the News: New Appointments at Biocept, Novacyt, Centogene, Illumina, More In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The Scan Interfering With Invasive Mussels The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels. Participation Analysis A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports. Right Whales' Decline A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC. Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.